Philippines Radiotherapy Market To Surpass US$ 27.7 Mn Threshold By 2028, At a CAGR of 5.8% during the forecast period (2021–2028)
Philippines Radiotherapy Market To Surpass US$ 27.7 Mn Threshold By 2028, At a CAGR of 5.8% during the forecast period (2021–2028)
Published by Coherent Market Insights
Posted on September 27, 2021
Radiation therapy or radiotherapy is a cancer treatment therapy, which uses high doses of radiations to kill cancer cells and shrink tumors. Several types of radiotherapies such as external beam radiation therapy, internal beam radiation therapy/ brachytherapy, and systemic radiation therapy are available to combat various types of cancers prevalent, globally. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.
Key participants for business development are Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc., Isoray Inc., Nordion Inc., Becton, Dickinson and Company, Ion Beam Applications SA, and Hitachi, Ltd.
Installment of novel technologically advanced radiotherapy equipment in Philippines for the treatment of various types cancer is expected to drive the Philippines radiotherapy market growth over the forecast period.
For instance, in 2015, the Philippine Gamma Knife Center at Manila’s Cardinal Santos Medical Center acquired Elekta’s Leksell Gamma Knife Perfexion stereotactic radiosurgery system, an advanced radiosurgery device with high accuracy, which is used for the treatment of brain and neck tumors.
High prevalence of cancers in Philippines is expected to be another factor increasing demand for radiotherapy for its treatment and significantly support Philippines radiotherapy market growth in near future.
As per the Philippine Cancer Society estimates in 2015, around 2,104 people suffered from leukemia, which accounts for 3% of the total cancer cases and around 1,160 people suffered from non-Hodgkin Lymphoma, which accounts for around 2% of all cancer cases
Furthermore, rising geriatric population in Philippines is expected to increase the chances of prostate cancer in males, which in turn is expected to increase demand for novel treatments such as radiotherapy for its treatment. For instance, according to the HelpAge, there were around 5,905,000 old people in Philippines in 2012, which is expected to reach around 23,633,000 by 2050.
Reasons to Purchase this Report
Current and future of global Philippines Radiotherapy market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Radiation therapy or radiotherapy is a cancer treatment therapy, which uses high doses of radiations to kill cancer cells and shrink tumors. Several types of radiotherapies such as external beam radiation therapy, internal beam radiation therapy/ brachytherapy, and systemic radiation therapy are available to combat various types of cancers prevalent, globally. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.
Key participants for business development are Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc., Isoray Inc., Nordion Inc., Becton, Dickinson and Company, Ion Beam Applications SA, and Hitachi, Ltd.
Installment of novel technologically advanced radiotherapy equipment in Philippines for the treatment of various types cancer is expected to drive the Philippines radiotherapy market growth over the forecast period.
For instance, in 2015, the Philippine Gamma Knife Center at Manila’s Cardinal Santos Medical Center acquired Elekta’s Leksell Gamma Knife Perfexion stereotactic radiosurgery system, an advanced radiosurgery device with high accuracy, which is used for the treatment of brain and neck tumors.
High prevalence of cancers in Philippines is expected to be another factor increasing demand for radiotherapy for its treatment and significantly support Philippines radiotherapy market growth in near future.
As per the Philippine Cancer Society estimates in 2015, around 2,104 people suffered from leukemia, which accounts for 3% of the total cancer cases and around 1,160 people suffered from non-Hodgkin Lymphoma, which accounts for around 2% of all cancer cases
Furthermore, rising geriatric population in Philippines is expected to increase the chances of prostate cancer in males, which in turn is expected to increase demand for novel treatments such as radiotherapy for its treatment. For instance, according to the HelpAge, there were around 5,905,000 old people in Philippines in 2012, which is expected to reach around 23,633,000 by 2050.
Reasons to Purchase this Report
Current and future of global Philippines Radiotherapy market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players